Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

作者: Babur Yusufi , Sujoy Mukherjee , Robert Flanagan , Carol Paton , Graham Dunn

DOI: 10.1097/YIC.0B013E32819F8F17

关键词:

摘要: Clozapine is associated with non-neurological side effects that can be subjectively unpleasant and/or clinically serious. We sought to: (i) assess the nature and prevalence of experienced by patients receiving maintenance treatment clozapine (ii) explore relationship between plasma concentration effect burden. Patients were treatment. Open questioning followed systematic enquiry using Antipsychotic Non-neurological Side Effects Rating Scale used to effects. Trough norclozapine concentrations measured. One hundred three participated. On open questioning, 61 reported a total 117 effects, whereas identified an additional 649 each patient reporting at least one. significantly but weakly correlated score (Pearson correlation=0.29, P 0.25 mg/l more likely have moderate/severe than lower (63/76 vs. 12/23, chi=9.07, d.f.=1, P<0.01). The side-effect burden high true extent only ascertained inquiry. use target below those for acute should explored as strategy minimizing

参考文章(36)
Thomas R. E. Barnes, Mike A. McPhillips, Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. The British journal of psychiatry. Supplement. ,vol. 174, pp. 34- 43 ,(1999) , 10.1192/S0007125000298097
Perry Pj, Therapeutic drug monitoring of antipsychotics. Psychopharmacology Bulletin. ,vol. 35, pp. 19- 29 ,(2001)
R J Cadoret, D D Miller, P J Perry, S V Arndt, Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry. ,vol. 148, pp. 231- 235 ,(1991) , 10.1176/AJP.148.2.231
R. W. Baker, J. Baird, N. R. Schooler, K. N. R. Chengappa, M. D. Shelton, J. Delaney, The prevalence of akathisia in patients receiving stable doses of clozapine. The Journal of Clinical Psychiatry. ,vol. 55, pp. 142- 145 ,(1994)
B Gulasekaram, K Sitanggan, S G Potkin, G Richmond, J Costa, S Hayes, R Bera, D Carreon, B Gerber, Y Jin, Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. The Journal of Clinical Psychiatry. ,vol. 55, pp. 133- 136 ,(1994)
Tore Haslemo, Per Haakon Eikeseth, Lars Tanum, Espen Molden, Helge Refsum, The effect of variable cigarette consumption on the interaction with clozapine and olanzapine European Journal of Clinical Pharmacology. ,vol. 62, pp. 1049- 1053 ,(2006) , 10.1007/S00228-006-0209-9
Karen Atkin, Francis Kendall, Duncan Gould, Hugh Freeman, Jeffrey Lieberman, Desmond O'Sullivan, Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. British Journal of Psychiatry. ,vol. 169, pp. 483- 488 ,(1996) , 10.1192/BJP.169.4.483
Thomas R. E. Barnes, A rating scale for drug-induced akathisia. British Journal of Psychiatry. ,vol. 154, pp. 672- 676 ,(1989) , 10.1192/BJP.154.5.672